Searched for
NOVAVAX SHOT
FDA approves Novavax COVID vaccine with new conditionsThe FDA has approved Novavax's COVID-19 vaccine, Nuvaxovid, but with restrictions. It's authorized for individuals 65 and older, and those ...- Novavax awaits FDA decision on whether its next COVID shot can be offered in USNovavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator tol...
- Novavax soars 146% on $1.2 billion Sanofi vaccine licensing dealThe pact links two big players in the vaccine world that both missed out on the rush to develop and commercialize Covid shots quickly durin...
- France's Sanofi signs COVID-19 vaccine deal with NovavaxSanofi and Novavax partnered for a COVID-19 vaccine deal. Novavax will receive $1.2 billion in milestones. Sanofi will take an equity stake...
- Covid in US: Free rapid coronavirus tests to begin in schools. Here's whyUS government has decided to conduct free rapid coronavirus tests in schools. Summer surge in COVID-19 cases sparked debates about masking ...
- Novavax lays off 25% of workforce, releases 2023 outlookBiotech firm Novavax is reducing its global workforce by 25% as it pushes ahead with cost-cutting measures aimed at dealing with sluggish d...
- Serum Institute gets USFDA nod to export Novavax covid jab to USThe USFDA approval makes SII - the first Indian vaccine maker to export vaccines to the US market, a testimony to the company's abilities t...
- Novavax shares skyrocketed as FDA recommends the Vaccine for Covid19 in the U.SProtein-based covid shot, Novavax has received a recommendation by US Food and drug administration(FDA), which can make it the 4th option f...
- View: To vaccinate the world, we need to look beyond mRNAAccelerating global vaccinations is the only way to ensure we don’t ruin 2022 or 2023 with yet worse variants.
- Novavax says COVID vaccine triggers immune response to Omicron variantNovavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization.
- EU approves 5th COVID-19 vaccine for bloc, one by NovavaxThe Novavax shot joins those from Pfizer-BioNTech, Moderna, Johnson & Johnson and AstraZeneca in the EU's vaccine armory.
- Serum Institute of India hopes to launch Novavax Covid-19 vaccine for children in six monthsThe Novavax shot, which the world's largest producer of vaccines calls Covovax, has shown good results in trials in children aged three and...
- Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response: Lancet studyIf the AstraZeneca-Oxford vaccine is followed by a Moderna or Novavax shot, higher antibodies and T-cell responses were induced versus two ...
- Serum Institute delivers first Novavax shot through COVAXThe world's biggest vaccine maker exported 137,500 doses of Covovax, as it calls the shot, to the Southeast Asian country last week. Indone...
- Novovax, Serum Institute seek WHO's approval for their COVID vaccineThe Novavax shots are easier to store and transport than some other options. They've long been expected to play an important role in increa...
- Novavax set for India launch with Serum Institute as manufacturing partnerThe large Novavax trials conducted on 29,960 persons in the US and Mexico have delivered results that equal the Pfizer and Moderna jabs and...
- Novavax: Large study finds COVID-19 shot about 90% effectiveWhile demand for COVID-19 shots in the US has dropped off dramatically, the need for more vaccines around the world remains critical. The N...
- Serum’s launch of Novavax shot in India may face delayAdar Poonawalla had complained in the past that the manufacturing of the Novavax vaccine was getting delayed due to a shortage of raw mater...
- Novavax Covid vaccine results to put 1,190% stock surge to testThe biotech firm said in March its shot could get cleared by the Food and Drug Administration for emergency use as early as May.
- Indian entrepreneur’s stake in US vaccine company soars to Rs 400 croreNovavax calls itself a late-stage biotechnology company. Its Covid-19 vaccine candidate was developed using the company’s recombinant nanop...
Load More
